'Tamper-evident' benefits are evident

28 Feb 2019

2019 will mark Uniplast's debut at this year's edition of CPhI Worlwide in Frankfurt, where it will showcase its expertise in plastic packaging.

Pharmaceutical packaging serves numerous purposes and comes in a variety of materials and designs, depending on the drug product.

'Tamper-evident' benefits are evident

Uniplast - a regional leader in the manufacture and distribution of pharmaceutical, medical and cosmetic packaging - has used its 27 years of operational expertise and knowhow to develop more than 150 different high-quality products.

Tamper-proof bottles that save time and reduce contamination

The company is renowned for its variety of plastic packaging, particularly its bottles with a tamper-proof cap and integrated dropper, which reduces the packaging process from three to two steps, thereby saving time in product filling and packing, and reduces the risk of contamination while handling the sterile products. These plastic bottles are used for storing liquid pharmaceutical products (magistral medicine, galenical medicine, ready-made medicines, and pharmaceutical substance) and can be in direct contact with the product. Customers can choose the colour of the container

Compliance and certification

Demonstrating its compliance with various regulatory standards, Uniplast's plastic containers and closures are manufactured in accordance with the following: ISO 9001, ISO 14001, OHSAS 18001 and ISO 15378. In 2017, Uniplast implemented ISO 13485, regarding the production, development and sale of sterile and nonsterile IVDs, urine cups, Petri dishes, and swab and faeces containers.

The Uniplast team's creative environment motivates and inspires all those that are in touch with their products and services. Uniplast customers can expect a relationship based on 100% trust and fair co-operation to ensure superior quality products that will improve their sales and facilitate the way to success.

Read More

Related news

Lessons learned from early EU FMD adopters

Lessons learned from early EU FMD adopters

13 May 2019

Data exchange, investment costs, resources and hardware identified as some of the biggest challenges.

Read more 
Brexit's trick or treat on patient safety

Brexit's trick or treat on patient safety

29 Apr 2019

Despite a delayed Brexit, unpredictability adds further complications to the EU FMD regulation.

Read more 
Surge of Indian biosimilars market forecast in 2019

Surge of Indian biosimilars market forecast in 2019

22 Apr 2019

India predicted to be one of the world’s ‘fastest growing bio’ hubs in 2019, fuelled by new biosimilars production.

Read more 
RAPS on delayed Brexit

RAPS on delayed Brexit

26 Mar 2019

The post-Brexit regulatory environment continues to weigh heavily on the minds of regulatory professionals.

Read more 
Sizeable growth potential for global drug delivery and packaging in 2019

Sizeable growth potential for global drug delivery and packaging in 2019

19 Mar 2019

Patient-centricity, eco-friendly and smart packaging trends marked as the biggest growth drivers and innovations in 2019.

Read more 
All Recipharm facilities ready for EU serialisation, regardless of Brexit

All Recipharm facilities ready for EU serialisation, regardless of Brexit

15 Feb 2019

The CDMO invested EUR 35 million into its operations and launched a 3-year programme to provide a compliant serialisation solution for its customers.

Read more 
Brexit - the EU FMD's painful problem

Brexit - the EU FMD's painful problem

7 Feb 2019

Teething problems are no stranger to the implementation of new regulations, but with the EU FMD, Brexit came like a set of wisdom teeth – late, painful and problematic.

Read more 
Pharmapack report predicts diversification of innovation leading to a rise in licensing and partnering

Pharmapack report predicts diversification of innovation leading to a rise in licensing and partnering

27 Jan 2019

New report highlights Germany, France and Switzerland as tier-one nations for ‘drug delivery innovation’, and warns the challenge will be to scale-up and approve promising prototypes.

Read more 
New API screening program strengthens Particle Sciences' nanomilling offering

New API screening program strengthens Particle Sciences' nanomilling offering

22 Jan 2019

Advanced formulation techniques such as nanomilling may provide an excellent route to improved bioavailability and enhanced therapeutic effect.

Read more 
Univercells introduces breakthrough vaccine manufacturing platform

Univercells introduces breakthrough vaccine manufacturing platform

13 Jan 2019

The automated NevoLine bioproduction system that facilitates safer, faster and closed bioprocessing in a much smaller footprint.

Read more